Abstract:: The impact of genetic variants on gene expression has been intensely studied at the transcription level, yielding invaluable insights into the association between genes and the risk of complex disorders, such as schizophrenia (SCZ). However, the downstream impact of these variants and the molecular mechanisms connecting transcription variation to disease risk are not well understood. : We quantitated ribosome occupancy in prefrontal cortex samples of the BrainGVEX cohort. Together with transcriptomics and proteomics data from the same cohort, we performed cis-Quantitative Trait Locus (QTL) mapping and identified 3,253 expression QTLs (eQTLs), 1,344 ribosome occupancy QTLs (rQTLs), and 657 protein QTLs (pQTLs) out of 7,458 genes from 185 samples. Of the eQTLs identified, only 34% have their effects propagated to the protein level. Further analysis on the effect size of prefrontal cortex eQTLs identified from an independent dataset clearly replicated the post-transcriptional attenuation of eQTL effects. We identified omics-specific QTLs and investigated their potential in driving disease risks. Using a variant based approach, we found expression-specific QTLs (esQTLs) for 1,553 genes, ribosome-occupancy-specific QTLs (rsQTLs) for 155 genes, and protein-specific QTLs (psQTLs) for 161 genes. Among these omics-specific QTL, 38 showed strong colocalization with brain associated disorder GWAS signals, 29 of them are esQTLs. Because a gene could contain multiple QTL signals, each could either be shared across omics or omics-specific, we aggregated QTL signals from each omics for each gene and found 11 brain associated disorder risk genes that are driven predominantly by omics-specific QTL, all of them are driven by variants impacting transcriptional regulation. This gene-based approach also enabled us to categorize risk genes containing both omics-specific and shared QTL signals. The limited number of GWAS colocalization discoveries from gene-based omics-specific mapping, however, prompted us to take a complementary approach to investigate the functional relevance of genes driven predominantly by attenuated eQTL signals. Using S-PrediXcan we identified 74 SCZ risk genes across the three omics, 30% of which were novel, and 67% of these risk genes were confirmed to be causal in a MR-Egger test using data from the corresponding omics. Notably, 52 out of the 74 risk genes were identified using eQTL data and 68% of these SCZ-risk-gene-driving eQTLs show little to no evidence of driving corresponding variations at the protein level. : The effect of eQTLs on gene expression in the prefrontal cortex is commonly attenuated post-transcriptionally. Many of the attenuated eQTLs still correlate with GWAS signals of brain associated complex disorders, indicating the possibility that these eQTL variants drive disease risk through mechanisms other than regulating protein expression level. Further investigation is needed to elucidate the mechanistic link between attenuated eQTLs and brain associated complex disorders.

Genetic Control of the Human Brain Proteome

The genetic landscape of neuro-related proteins in human plasma

Genetic regulation of human brain proteome reveals proteins implicated in psychiatric disorders

Genetic regulation of cell type–specific chromatin accessibility shapes brain disease etiology

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease

Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders

TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma

Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases

Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain

Genetic Modulation of Protein Expression in Rat Brain

Single-Nucleus Atlas of Cell-Type Specific Genetic Regulation in the Human Brain

Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits

Single-cell genomics and regulatory networks for 388 human brains

Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis

Human brain proteome-wide association study provides insights into the genetic components of protein abundance in obesity

Expression QTL Studies in LOAD and PSP Brains by Next-Generation RNA Sequencing (I5-1.009)

A transcriptomic atlas of the human brain reveals genetically determined aspects of neuropsychiatric health

Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLs

P2‐025: Genetic and Epigenetic Influences on Brain Gene Expression in Psp

The impact of common variants on gene expression in the human brain: from RNA to protein to schizophrenia risk

Genetic control of individual differences in gene-specific methylation in human brain.